Argos Therapeutics (FRA:77AA) Other Long Term Assets : €0.01 Mil (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Other Long Term Assets?

Argos Therapeutics's other long-term assets for the quarter that ended in Sep. 2018 was €0.01 Mil.

Argos Therapeutics's quarterly other long-term assets increased from Mar. 2018 (€0.01 Mil) to Jun. 2018 (€0.01 Mil) but then stayed the same from Jun. 2018 (€0.01 Mil) to Sep. 2018 (€0.01 Mil).

Argos Therapeutics's annual other long-term assets increased from Dec. 2015 (€0.01 Mil) to Dec. 2016 (€0.71 Mil) but then declined from Dec. 2016 (€0.71 Mil) to Dec. 2017 (€0.01 Mil).

Argos Therapeutics Other Long Term Assets Historical Data

The historical data trend for Argos Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Other Long Term Assets Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Other Long Term Assets

Get a 7-Day Free Trial

1.08

0.01

0.71

0.01

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Other Long Term Assets	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Argos Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines